Quadruple antigenic epitope peptide producing immune protection against classical swine fever virus

Vaccine

Volumn 24, Issue 49-50, 2006, Pages 7175-7180

  Liu, Siguo ^a,b   Yu, Xinglong ^a   Wang, Chunlai ^b   Wu, Jianmin ^a   Kong, Xiangang ^b   Tu, Changchun ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

CSFV; E2 glycoprotein; Protective immunity; Repeated epitope peptide

Indexed keywords

EPITOPE; GLUTAMINYLTHREONYLALANYLVALYLSERYLPROLYLTHREONYLTHREONYL LEUCYLARGINYLTHREONYLGLUTAMYLVALYLVALYLLYSINE; GLUTAMINYLTHREONYLALANYLVALYLTHREONYLPROLYLTHREONYLTHREONYL LEUCYLARGINYLTHREONYLGLUTAMYLVALYLVALYLLYSINE; GLUTATHIONE TRANSFERASE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; IMMUNITY; IMMUNOGENICITY; IMMUNOREACTIVITY; NONHUMAN; PESTIVIRUS; PRIORITY JOURNAL; RABBIT; SWINE; SWINE DISEASE; VACCINATION; VIRULENCE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIGENS, VIRAL; BLOTTING, WESTERN; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GLUTATHIONE TRANSFERASE; RABBITS; SWINE; VACCINES, SYNTHETIC;

EID: 33846210671     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.06.042     Document Type: Article

References (40)

1. Terpstra C. Special review series: Hog cholera: an update of present knowledge. Br Vet J 147 (1991) 397-406
2. Heinz F.X., Collett M.S., Purcekk R.H., Gould E.A., Howard C.R., Houghton M., et al. Family Flaviridae. In: van Regenmortel M.H.V., Fauquet C.M., Bishop D.H.L., Carstens E.B., Estes M.K., Lemon S.M., Maniloff J., Mayo M.A., McGeoch D.J., Pringle C.R., and Wickner R.B. (Eds). Virus taxonomy. Seventh report of the international committee on taxonomy of virus (2000), Academic Press, San Diego 859-878
3. Thiel H.J., Stark R., Weiland E., Rumenapf T., and Meyers G. Hog cholera virus: molecular composition of virions from a pestivirus. J Virol 65 (1991) 4705-4712
4. Hulst M.M., Westra D.F., Wensvoort G., and Moormann R.J. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J Virol 67 (1993) 5435-5442
5. Rumenapf T., Stark R., Meyers G., and Thiel H.J. Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J Virol 65 (1991) 589-597
6. Weiland E., Ahl R., Stark R., Weiland F., and Thiel H.J. A second glycoprotein mediates neutralization of a pestivirus, hog cholera virus. J Virol 66 (1992) 3677-3682
7. Weiland E., Stark R., Haas B., Rumenapf T., Meyers G., and Thiel H.J. Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer. J Virol 64 (1990) 3563-3569
8. Konig M., Lengsfeld M., Pauly T., Stark R., and Thiel H.J. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J Virol 69 (1995) 479-486
9. van Rijn P.A., de Meijer E.J., van Gennip H.G., and Moormann R.J.M. Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia. J Gen Virol 74 (1993) 2053-2060
10. van Rijn P.A., Miedema G.K.W., Wensvoort G., van Gennip H.G., and Moormann R.J.M. Antigenic structure of envelope glyco-protein E1 of hog cholera virus. J Virol 68 (1994) 3934-3942
11. Greiser-Wilke I., Moennig V., and Iess B.L. Identification of conserved epitopes on a hog cholera virus protein. Arch Virol 111 (1998) 213-225
12. Bouma A., de Smit A.J., de Kluijver E.P., Terpstra P., and Moormann R.J.M. Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus. Vet Microbiol 66 (1999) 101-114
13. van Rijn P.A., Bossers A., Wensvoort G., and Moormann R.J.M. Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. J Gen Virol 77 (1996) 2737-2745
14. van Rijn P.A., van Gennip H.G., and Moormann R.J.M. An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV). Vaccine 17 (1999) 433-440
15. Moormann R.J.M., Bouma A., Kramps J.A., Terpstra C., and de Smit H.J. Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Vet Microbiol 73 (2000) 209-219
16. Rumenapf T., Stark R., Meyers G., and Thiel H.J. Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J Virol 65 (1991) 589-597
17. van Zijl M., Wensvoort G., de Kluyver E., Hulst M., van der Gulden H., Gielkens A., et al. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J Virol 65 (1991) 2761-2765
18. Hammond J.M., Jansen E.S., Morrissy C.J., Hodgson A.L., and Johnson M.A. Protection of pigs against in contact challenge with classical swine fever following oral or subcutaneous vaccination with a recombinant porcine adenovirus. Virus Res 97 (2003) 151-157
19. Hammond J.M., McCoy R.J., Jansen E.S., Morrissy C.J., Hodgson A.L., and Johnson M.A. Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever. Vaccine 18 (2000) 1040-1050
20. Ganges L., Barrera M., Nunez J.I., Blanco I., Frias M.T., Rodriguez F., et al. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge. Vaccine 23 (2005) 3741-3752
21. Yu X., Tu C., Li H., Hu R., Chen C., Li Z., et al. DNA-mediated protection against classical swine fever virus. Vaccine 19 (2001) 1520-1525
22. Lin M., Lin F., Mallory M., and Clavijo A. Deletions of structural glycoprotein E2 of classical swine fever virus strain Alfort/187 resolve a linear epitope of monoclonal antibody WH303 and the minimal N-terminal domain essential for binding immunoglobulin G antibodies of a pig hyperimmune serum. J Virol 74 (2000) 11619-11625
23. Zhang F., Yu M., Weiland E., Morrissy C., Zhang N., Westbury H., et al. Characterization of epitopes for neutralizing monoclonal antibodies to classical swine fever virus E2 and E(rns) using phage-displayed random peptide library. Arch Virol 151 (2006) 37-54
24. Liu S., Tu C., Wang C., Yu X., Wu J., Guo S., et al. The protective immune response induced by B cell epitope of classical swine fever virus glycoprotein E2. J Virol Meth 134 (2006) 125-129
25. Yu X., Tu X., Xu X., Zhang M., Chen Y., and Liu B. Site-directed mutagenesis of the major antigen E2 gene of CSFV, its high level expression in Escherichia coli and the immunonicity of recombinant E2 protein. Chin J Biotechnol 19 (2003) 439-443
26. Yu X., Tu C., Li H., Chen C., Li Z., Ma Z., et al. Construction of eukaryotic expression plasmids of CSFV E2 gene and the study on DNA vaccine. Virol Sin 15 (2000) 264-272
27. Bradford M.M. A Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
28. Colijn E.O., Bloemraad M., and Wensvoort G. An improved ELISA for the detection of serum antibodies directed against classical swine fever virus. Vet Microbiol 63 (1998) 81-83
29. Sambrook J., and Russell D. Molecular cloning: a laboratory manual. 3rd ed. (2000), Cold Spring Harbour Laboratory, Cold Spring Harbour, NY
30. Chauhan N., Kumar R., Badhai J., Preet A., and Yadava P.K. Immunogenicity of cholera toxin B epitope inserted in Salmonella flagellin expressed on bacteria and administered as DNA vaccine. Mol Cell Biochem 276 (2005) 1-6
31. Itoh T., and Celis E. Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective anti-tumor immunity in mice. J Immunother 28 (2005) 430-437
32. Wang Z., Liu Z., Cheng X., and Chen Y.H. The recombinant immunogen with high-density epitopes of ELDKWA and ELDEWA induced antibodies recognizing both epitopes on HIV-1 gp41. Microbiol Immunol 49 (2005) 703-709
33. *10 presents an immundominant SIV Gag epitope: identification, tetramer development and implications of immune escape and reversion. J Med Primatol 34 (2005) 282-293
34. Dong X.N., Wei K., Liu Z.Q., and Chen Y.H. Candidate peptide vaccine induced protection against classical swine fever virus. Vaccine 21 (2002) 167-173
35. Broekhuijsen M.P., Blom T., van Rijn J., Pouwels P.H., Klasen E.A., Fasbender M.J., et al. Synthesis of fusion protein with multiple copies of an antigenic determinant of foot-and-mouth disease virus. Gene 49 (1986) 189-197
36. Dong X.N., Qi Y., Ying J., Chen X., and Chen Y.H. Candidate peptide-vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2. Vaccine 24 (2006) 426-434
37. Dong X.N., Chen Y., Wu Y., and Chen Y.H. Candidate multi-peptide-vaccine against classical swine fever virus induced potent immunity with serological marker. Vaccine 23 (2005) 3630-3633
38. DiMarchi R., Gale G., Brooke C., Cracknell V., Doel T.R., and Mowat N. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232 (1986) 639-641
39. Bittle J.L., Houghten R.A., Alexander H., Shinnick T.M., Sutcliffe J.G., Lerner R.A., et al. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298 (1982) 30-33
40. Broekhuijsen M.P., van Rijn J.M., Blom A.J., Pouwels P.H., Enger-Valk B.E., Brown F., et al. Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals. J Gen Virol 68 (1987) 3137-3143